Genetic biomarkers for the survival of kidney cancer patients
Previously, researchers found some genes that helped identify which patients [...]
Previously, researchers found some genes that helped identify which patients [...]
Researchers are interested in the bacteria in our gut (the [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with nivolumab plus cabozantinib have been [...]
A recent post hoc analysis of the CheckMate 214 trial [...]
A recent study published in Journal of Clinical Medicine this [...]
The Scottish Medicines Consortium (SMC) has approved the use of [...]
The use of two medicines together (combination therapies) for previously [...]
Ipilimumab plus nivolumab is a standard first-line treatment for patients [...]
Recent evidence suggests that the bacteria in the gut (the [...]